跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BEQVEZ - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BEQVEZ
Authorized
STANDARD
BEQVEZ
Pfizer Canada Ulc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
43d0b8e70881cc68
Company
Pfizer Canada Ulc
Type
Standard
Approval Details
Approval Id
43d0b8e70881cc68
Drug Approval Canada Name
BEQVEZ
Product Name
BEQVEZ
Status
Cancelled Pre Market
Status Date
2025-06-10
Din
02544156
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Schedule D , Prescription
Ahfs
26:12.00
Atc Original
B02BD17 FIDANACOGENE ELAPARVOVEC
Atc Name
b 02 bd 17
Aig Number
0165602001
Company Name
Pfizer Canada Ulc
Company Address
17300 Trans-Canada Highway, Kirkland, Quebec, Canada, H9J 2M5
Company Detail Path
/organization/pfizer-canada-ulc
Company Information
Pharmaceutical Company Name
Pfizer Canada Ulc
Country Name
Canada
Province Name
Quebec
City Name
kirkland,quebec,country_ca
Address
17300 rte Transcanadienne
Active Ingredients
FIDANACOGENE ELAPARVOVEC
10000 BVG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
43d0b8e70881cc68
Type
Standard
Back to Health Canada Approvals